Porteus, Matthew, Md
Clinical trials sponsored by Porteus, Matthew, Md, explained in plain language.
-
New cell therapy aims to reduce chemo side effects for rare blood disease
Disease control Recruiting nowThis study tests a new way to do stem cell transplants for people with Fanconi Anemia, a rare genetic condition that causes bone marrow failure. Instead of strong chemotherapy, patients get a milder prep treatment that includes an experimental antibody called JSP191. The goal is …
Phase: PHASE1, PHASE2 • Sponsor: Porteus, Matthew, MD • Aim: Disease control
Last updated May 26, 2026 07:16 UTC
-
New cell therapy aims to supercharge immune recovery after stem cell transplant for young cancer patients
Disease control Recruiting nowThis early-phase study tests a cell therapy called T-allo10 given after a special stem cell transplant (αβ depleted-HSCT) in children and young adults with blood cancers. The goal is to see if it safely helps rebuild the immune system faster, without causing severe graft-versus-h…
Phase: PHASE1 • Sponsor: Porteus, Matthew, MD • Aim: Disease control
Last updated May 22, 2026 13:55 UTC